Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term InvestmentsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecuritiesSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MetroCity Bankshares (MCBS) Cash & Equivalents: 2018-2025

Historic Cash & Equivalents for MetroCity Bankshares (MCBS) over the last 6 years, with Sep 2025 value amounting to $227.2 million.

  • MetroCity Bankshares' Cash & Equivalents fell 22.00% to $227.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.2 million, marking a year-over-year decrease of 22.00%. This contributed to the annual value of $249.9 million for FY2024, which is 72.56% up from last year.
  • MetroCity Bankshares' Cash & Equivalents amounted to $227.2 million in Q3 2025, which was down 20.58% from $286.0 million recorded in Q2 2025.
  • In the past 5 years, MetroCity Bankshares' Cash & Equivalents ranged from a high of $441.3 million in Q4 2021 and a low of $144.8 million during Q4 2023.
  • Over the past 3 years, MetroCity Bankshares' median Cash & Equivalents value was $262.7 million (recorded in 2023), while the average stood at $258.2 million.
  • In the last 5 years, MetroCity Bankshares' Cash & Equivalents skyrocketed by 192.88% in 2021 and then slumped by 59.33% in 2022.
  • MetroCity Bankshares' Cash & Equivalents (Quarterly) stood at $441.3 million in 2021, then slumped by 59.33% to $179.5 million in 2022, then fell by 19.32% to $144.8 million in 2023, then surged by 72.56% to $249.9 million in 2024, then decreased by 22.00% to $227.2 million in 2025.
  • Its Cash & Equivalents was $227.2 million in Q3 2025, compared to $286.0 million in Q2 2025 and $285.1 million in Q1 2025.